
Nyxoah S.A.
NYXHNASDAQHealthcareMedical - Specialties
أحدث البيانات المتاحة
1.36 US$
+0.01 US$ · +0.74%
NYXH نظرة عامة على الشركة
ملف الشركة
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.











